Sacrocolpopexy experience with a novel robotic surgical platform

Introduction and hypothesis The objective was to describe early experience performing sacrocolpopexy using a novel robotic surgical platform. Methods This is a case series of all women who underwent robotic-assisted sacrocolpopexy using a new robotics platform (TransEnterix Senhance) between January 2019 and July 2021. All sacrocolpopexies were performed by a single Female Pelvic Medicine and Reconstructive surgeon at a large academic institution. Perioperative information including complications was abstracted from the medical record. Anatomical recurrence was defined as any anatomical point at or past the hymen (>= 0). Data are descriptive, with Mann-Whitney U test used for comparison of operative time between the first and second half of the patients. Results A total of 25 sacrocolpopexies were performed using the new robotics platform. Mean age was 62.3 years (+/- 9.2) and mean BMI was 26.5 (+/- 3.8). Ten (40.0%) patients had a prior hysterectomy. Most (n = 21, 84.0%) had stage III or IV prolapse preoperatively. Mean operative time was 210.2 min (+/- 48.6) and median estimated blood loss was 35 ml (IQR 25-50). Mean operative time decreased between the first and second half of the patients (231.7 min vs 190.3 min, p = 0.047). There were no major intraoperative complications. Median follow-up time was 16 weeks (IQR 4-34) and there were no subjective recurrences or retreatments during this period. Two patients (8.0%) had anatomical recurrence without subjective bother. There were two postoperative readmissions (8.0%) within 30 days for small bowel obstruction, one treated surgically and the other with nonsurgical management. Conclusions Our case series demonstrates feasibility and successful early adoption of a new robotics platform for robotic sacrocolpopexy.